|

CT7439 Capsules (0.5 mg, 1mg, 3mg) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Carrick Therapeutics Limited1

Indications

  • Solid Malignancies1
  • Cancer1

Dallas, Texas1 trial

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

Research site 03

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.